| Filed On | Filing |
|---|---|
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis |
| 01 Sep 2026 |
8-K: Other Events
On August 31, 2026, ResMed Inc. (the “Company”) entered into an accelerated share repurchase agreement (the “ASR Agreement”) with Citibank, N.A. (“Citibank”) to repurchase $450.0 million of the Company’s shares of common stock, par value... |
| 17 Aug 2026 |
8-K: Changes in Registrant's Certifying Accountant; Departure/Election of Directors or Officers; Compensation +1 more
Nominating and Governance Chair Carol Burt to become Lead Director. |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Q4 revenue increased by 9% to a record $1.5 billion; up 8% on a constant currency basis |
| 07 Jul 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Sharpens Resmed’s focus on high-growth sleep and connected care markets |
| 30 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Brett Sandercock, Chief Financial Officer, ... |
| 30 Apr 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis |
| 29 Jan 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis |
| 20 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 30 Oct 2025 |
8-K: Results of Operations and Financial Condition; Other Events
Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis |
| 18 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations |
| 01 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 31 Jul 2025 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 10%, operating profit up 19%, non-GAAP operating profit up 19% |
| 23 Apr 2025 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 8%, operating profit up 14%, non-GAAP operating profit up 13% |
| 30 Jan 2025 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19% |
| 21 Nov 2024 |
8-K: Submission of Matters to a Vote of Security Holders
On November 20, 2024, at our annual meeting of stockholders, our stockholders (1) elected the eleven nominees listed below to serve on our board of directors; (2) ratified the selection of KPMG LLP as our independent registered public ac... |
| 24 Oct 2024 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27% |
| 16 Aug 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board |
| 01 Aug 2024 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 9%, operating profit up 38%, non-GAAP operating profit up 30% |
| 25 Apr 2024 |
8-K: Results of Operations and Financial Condition; Other Events
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% |
Loading...